TELO

$0.00

(

+0.00%

) Quote details
Add to Watchlist Run Backtest
stock

Telomir Pharmaceuticals, Inc. Common Stock

NASDAQ | TELO

1.34

USD

+$0.00

(

+0.00%

)

At Close (As of Nov 28, 2025)

$45.38M

Market Cap

-

P/E Ratio

-0.37

EPS

$7.08

52 Week High

$1.12

52 Week Low

HEALTHCARE

Sector

TELO Chart

Recent Chart
Price Action

TELO Technicals

Tags:

TELO Earnings

Yearly Income Statement (As of Sep 30, 2024)

Field Value (USD)
Gross Profit -
Total Revenue $0
Cost Of Revenue -
Costof Goods And Services Sold -
Operating Income -$12M
Selling General And Administrative $9.6M
Research And Development $2.2M
Operating Expenses $12M
Investment Income Net -
Net Interest Income -$4.3M
Interest Income $48K
Interest Expense $4.3M
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $12M
Income Before Tax -$17M
Income Tax Expense -$17M
Interest And Debt Expense -
Net Income From Continuing Operations -$17M
Comprehensive Income Net Of Tax -
Ebit -$12M
Ebitda $48K
Net Income -$17M

Revenue & Profitability

Earnings Performance

TELO Financials

yearly Balance Sheet (As of Sep 30, 2024)

Field Value (USD)
Total Assets $1.3M
Total Current Assets $1.3M
Cash And Cash Equivalents At Carrying Value $1.3M
Cash And Short Term Investments $1.3M
Inventory -
Current Net Receivables -
Total Non Current Assets $0
Property Plant Equipment -
Accumulated Depreciation Amortization Ppe -
Intangible Assets -
Intangible Assets Excluding Goodwill -
Goodwill -
Investments -
Long Term Investments -
Short Term Investments -
Other Current Assets $58K
Other Non Current Assets -
Total Liabilities $681K
Total Current Liabilities $681K
Current Accounts Payable $588K
Deferred Revenue -
Current Debt -
Short Term Debt $93K
Total Non Current Liabilities $0
Capital Lease Obligations -
Long Term Debt -
Current Long Term Debt -
Long Term Debt Noncurrent -
Short Long Term Debt Total $93K
Other Current Liabilities $0
Other Non Current Liabilities -
Total Shareholder Equity $643K
Treasury Stock -
Retained Earnings -$31M
Common Stock -
Common Stock Shares Outstanding $30M

yearly Cash Flow (As of Sep 30, 2024)

Field Value (USD)
Operating Cashflow -$5.1M
Payments For Operating Activities -
Proceeds From Operating Activities -
Change In Operating Liabilities -
Change In Operating Assets -
Depreciation Depletion And Amortization $4.3M
Capital Expenditures $0
Change In Receivables -
Change In Inventory -
Profit Loss -
Cashflow From Investment -
Cashflow From Financing $6.3M
Proceeds From Repayments Of Short Term Debt -
Payments For Repurchase Of Common Stock -
Payments For Repurchase Of Equity -
Payments For Repurchase Of Preferred Stock -
Dividend Payout -
Dividend Payout Common Stock -
Dividend Payout Preferred Stock -
Proceeds From Issuance Of Common Stock -
Proceeds From Issuance Of Long Term Debt And Capital Securities Net -
Proceeds From Issuance Of Preferred Stock -
Proceeds From Repurchase Of Equity -
Proceeds From Sale Of Treasury Stock -
Change In Cash And Cash Equivalents -
Change In Exchange Rate -
Net Income -$17M

yearly Income Statement (As of Sep 30, 2024)

Field Value (USD)
Gross Profit -
Total Revenue $0
Cost Of Revenue -
Costof Goods And Services Sold -
Operating Income -$12M
Selling General And Administrative $9.6M
Research And Development $2.2M
Operating Expenses $12M
Investment Income Net -
Net Interest Income -$4.3M
Interest Income $48K
Interest Expense $4.3M
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $12M
Income Before Tax -$17M
Income Tax Expense -$17M
Interest And Debt Expense -
Net Income From Continuing Operations -$17M
Comprehensive Income Net Of Tax -
Ebit -$12M
Ebitda $48K
Net Income -$17M

TELO News

TELO Profile

Telomir Pharmaceuticals, Inc. Common Stock Profile

Sector: HEALTHCARE

Industry: BIOTECHNOLOGY

Telomir Pharmaceuticals, Inc. (Ticker: TELO) is a pre-clinical-stage biopharmaceutical company headquartered in Baltimore, Maryland, specializing in the development of innovative therapies for human stem cell disorders. Leveraging proprietary technologies, Telomir is committed to creating novel treatments that may significantly enhance health outcomes in the field of regenerative medicine. With a robust focus on research and development, the company seeks to establish itself as a leader in stem cell therapy, addressing substantial unmet medical needs while creating long-term value for its stakeholders as it transitions toward commercialization.

LPTX
+368.57%
$2.05
KTTA
+38.67%
$1.47
NVDA
-1.80%
$177.00
HBI
-1.82%
$6.47
AMZE
+21.21%
$0.48
VINE
+21.21%
$0.48
TLRY
-21.06%
$0.81
INTC
+10.18%
$40.56
BITF
+12.25%
$3.48
IPG
-1.95%
$24.57
TWOH
-15.38%
$0.00
BYND
-3.74%
$0.98
YGMZ
-9.59%
$0.11
AXDX
-61.36%
$0.03
BMNR
+4.34%
$33.12
CLSK
+12.26%
$15.10
ADAP
-15.14%
$0.05
RUBI
-26.17%
$0.15
ASST
-0.88%
$1.12
PLUG
+1.51%
$2.01
SOND
-23.45%
$0.12
SNAP
+0.91%
$7.68
RMBL
+60.50%
$3.21
LNW
-3.71%
$86.22
INHD
-0.99%
$0.22
ADD
-25.47%
$0.05
CHR
-3.48%
$0.04
BIYA
+17.05%
$0.29
AAL
+0.86%
$14.05
TSLA
+0.84%
$430.17
SRM
+53.27%
$10.30
CIFR
+6.26%
$20.35
BMNU
+8.84%
$8.18
ONMD
+30.28%
$1.85
ONDS
-4.12%
$7.90
MARA
+6.30%
$11.81
WULF
+4.51%
$15.51
NIO
+0.73%
$5.50
F
+0.68%
$13.28
BURU
+9.84%
$0.24
GPUS
-9.24%
$0.30
WLGS
-5.57%
$0.04
MTSR
-0.35%
$70.50
VALE
+0.79%
$12.61
SOFI
+4.31%
$29.72
GOOGL
+0.07%
$320.18
BTBT
+2.58%
$2.38
DEFT
+9.35%
$1.52
ADTX
+21.01%
$3.80
BTG
+3.35%
$4.62
DVLT
-4.69%
$2.03
GRAB
+2.44%
$5.45
ACHR
+4.00%
$7.79
AFMD
-34.94%
$0.18
PFE
+0.11%
$25.74
CRCL
+10.03%
$79.93
SMX
+250.80%
$61.04
KWM
+13.63%
$0.75
DNN
0.00%
$2.56
IBRX
+10.79%
$2.36
RIOT
+7.82%
$16.13
AMZN
+1.77%
$233.22
CAN
+9.78%
$1.01
AAPL
+0.46%
$278.85
NWTN
-9.09%
$0.70
AIIO
-9.09%
$0.70
AG
+12.73%
$15.23
WBD
+0.50%
$24.00
VEEE
+45.50%
$2.59
APLD
+8.66%
$27.10
GOOG
-0.05%
$320.12
NGD
+6.50%
$8.35
IREN
-1.32%
$47.81
RIG
+2.55%
$4.41
GRYP
-10.38%
$1.38
BAC
+1.24%
$53.65
MODV
-25.22%
$0.43
AMD
+1.53%
$217.53
RIVN
+4.20%
$16.86
SMR
+5.04%
$20.00
TMC
+19.38%
$6.96
CDE
+6.67%
$17.27
PLTR
+1.61%
$168.45
ITUB
+1.82%
$7.80
CRCA
+19.56%
$4.40
AGNC
+0.47%
$10.49
T
+0.77%
$26.02
AMC
+6.52%
$2.45
VHAI
-25.00%
$0.00
CRCG
+20.00%
$2.82
NVO
+1.31%
$49.35
MSTR
+0.87%
$177.18
NFLX
+1.35%
$107.58
SAND
-6.04%
$12.12
BBD
+0.54%
$3.70
BTE
+1.89%
$3.22
MSFT
+1.34%
$492.01
HBAN
+0.18%
$16.30
HL
+5.32%
$16.82
CRWV
-1.57%
$73.12
LPTX
+368.57%
$2.05
KTTA
+38.67%
$1.47
NVDA
-1.80%
$177.00
HBI
-1.82%
$6.47
AMZE
+21.21%
$0.48
VINE
+21.21%
$0.48
TLRY
-21.06%
$0.81
INTC
+10.18%
$40.56
BITF
+12.25%
$3.48
IPG
-1.95%
$24.57
TWOH
-15.38%
$0.00
BYND
-3.74%
$0.98
YGMZ
-9.59%
$0.11
AXDX
-61.36%
$0.03
BMNR
+4.34%
$33.12
CLSK
+12.26%
$15.10
ADAP
-15.14%
$0.05
RUBI
-26.17%
$0.15
ASST
-0.88%
$1.12
PLUG
+1.51%
$2.01
SOND
-23.45%
$0.12
SNAP
+0.91%
$7.68
RMBL
+60.50%
$3.21
LNW
-3.71%
$86.22
INHD
-0.99%
$0.22
ADD
-25.47%
$0.05
CHR
-3.48%
$0.04
BIYA
+17.05%
$0.29
AAL
+0.86%
$14.05
TSLA
+0.84%
$430.17
SRM
+53.27%
$10.30
CIFR
+6.26%
$20.35
BMNU
+8.84%
$8.18
ONMD
+30.28%
$1.85
ONDS
-4.12%
$7.90
MARA
+6.30%
$11.81
WULF
+4.51%
$15.51
NIO
+0.73%
$5.50
F
+0.68%
$13.28
BURU
+9.84%
$0.24
GPUS
-9.24%
$0.30
WLGS
-5.57%
$0.04
MTSR
-0.35%
$70.50
VALE
+0.79%
$12.61
SOFI
+4.31%
$29.72
GOOGL
+0.07%
$320.18
BTBT
+2.58%
$2.38
DEFT
+9.35%
$1.52
ADTX
+21.01%
$3.80
BTG
+3.35%
$4.62
DVLT
-4.69%
$2.03
GRAB
+2.44%
$5.45
ACHR
+4.00%
$7.79
AFMD
-34.94%
$0.18
PFE
+0.11%
$25.74
CRCL
+10.03%
$79.93
SMX
+250.80%
$61.04
KWM
+13.63%
$0.75
DNN
0.00%
$2.56
IBRX
+10.79%
$2.36
RIOT
+7.82%
$16.13
AMZN
+1.77%
$233.22
CAN
+9.78%
$1.01
AAPL
+0.46%
$278.85
NWTN
-9.09%
$0.70
AIIO
-9.09%
$0.70
AG
+12.73%
$15.23
WBD
+0.50%
$24.00
VEEE
+45.50%
$2.59
APLD
+8.66%
$27.10
GOOG
-0.05%
$320.12
NGD
+6.50%
$8.35
IREN
-1.32%
$47.81
RIG
+2.55%
$4.41
GRYP
-10.38%
$1.38
BAC
+1.24%
$53.65
MODV
-25.22%
$0.43
AMD
+1.53%
$217.53
RIVN
+4.20%
$16.86
SMR
+5.04%
$20.00
TMC
+19.38%
$6.96
CDE
+6.67%
$17.27
PLTR
+1.61%
$168.45
ITUB
+1.82%
$7.80
CRCA
+19.56%
$4.40
AGNC
+0.47%
$10.49
T
+0.77%
$26.02
AMC
+6.52%
$2.45
VHAI
-25.00%
$0.00
CRCG
+20.00%
$2.82
NVO
+1.31%
$49.35
MSTR
+0.87%
$177.18
NFLX
+1.35%
$107.58
SAND
-6.04%
$12.12
BBD
+0.54%
$3.70
BTE
+1.89%
$3.22
MSFT
+1.34%
$492.01
HBAN
+0.18%
$16.30
HL
+5.32%
$16.82
CRWV
-1.57%
$73.12
2025 © AfterPullback LTD

Charts powered by TradingView

Market data may be delayed by 15 minutes or more and is provided by financial exchanges or third-party providers. AfterPullback does not verify or guarantee its accuracy and assumes no responsibility to do so. This website is not operated by a licensed attorney, accountant, or financial advisor. Nothing on this site constitutes financial advice or replaces consultation with a qualified professional who understands your specific circumstances. Always consult a licensed financial advisor before making investment decisions.